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Summary.-cis-Dichlorodiammineplatinum(II) (cis-Pt(II)) can act as a radio-
sensitizer of hypoxic mammalian cells in vitro. Used in combination with misonid-
azole the level of sensitization achieved is greater than that seen with either drug
alone, anditis suggested thatthesecompounds sensitizebyindependent mechanisms.
For cells held at 37°C, cis-Pt(II) shows much greater toxicity to hypoxic cells than
to aerobic cells. In combination with misonidazole, no additional cytotoxic effect is
shown towards aerobic cells than that seen for cis-Pt(II) alone. However, there is
additional killing of hypoxic cells when they are treated with both drugs.
THE USE of misonidazole (MISO) as a
radiosensitizer of hypoxic cells in tumours
is well established (for review see Adams
et al., 1978). In addition, a potential role
for its use in chemotherapy is being con-
sidered because of the ability of this drug
to be preferentially cytotoxic towards
hypoxic cells (Hall & Roizin-Towle, 1975;
Moore et al., 1976; Sridhar et al., 1976;
Stratford & Adams, 1977). If MISO is to
be ofvalue in chemotherapy it is necessary
to use it in combination with drug(s)
which can sterilize the aerobic fraction of
tumour cells. We are currently studying
the cytotoxic effect of some common anti-
neoplastic drugs, including a cis-Platinum
complex, cis-dichlorodiammineplatinum-
(II) (cis-Pt(II)). cis-Pt(II) is a proven
cytotoxic agent (see Roberts & Thomson,
1979, for review) and can also act as a
radiosensitizer ofhypoxic cells (Richmond
& Powers, 1976; Richmond et al., 1977;
Douple & Richmond, 1978; Nias et al.,
1979). Therefore we have examined the
radiosensitizing and cytotoxic properties
of MISO and cis-Pt(II) in combination.
MATERIALS AND METHODS
Cells.-Chinese hamster V79-379A cells
used in this work were maintained in spinner
culture in Eagles' Minimal Essential Medium
(MEM) modified for suspension cultures (Flow
Laboratories Ltd.) supplemented with 7.5%
foetal calf serum (FCS, Gibco-Biocult Ltd.).
Cells were kept in log phase at concentrations
ranging between 105 and 106/ml.
Cytotoxicity experiments.-250ml spinner
flasks were fitted with a gas inlet/outlet
system and a sidearm through which samples
could be withdrawn. Asynchronous, log-
phase cells at a concentration of 2 x 105/ml
were suspended in MEM+7.5% FCS and held
in a water bath at 37TC. The compounds were
dissolved in MEM+7.5% FCS and added to
the suspension which was buffered with
bicarbonate to pH 7-4. When appropriate,
the spinner containing cells was deaerated by
flowing N2 plus 5% CO2 (<10 pts/106 02;
BOC Ltd) at 500 ml/min over the surface of
the stirred suspension throughout the experi-
ment. Samples of cells were withdrawn at
appropriate times, centrifuged, resuspended,
counted, diluted, plated in MEM+15% FCS
and incubated for 7-10 days at 37°C before
scoring for colony formation. Further details
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of the technique are described elsewhere
(Stratford & Adams, 1977).
Radiation experiments.-Cells were har-
vested from log-phase cultures, diluted
appropriately and added to glass Petri
dishes containing 2-5 ml MEM, supplemented
-v%ith 15% FCS. Cells were allowed to attach
at 37°C for 2-3 h before the medium was
removed and replaced with fresh medium
containing drug(s). Irradiations with 60Co
y-rays were carried out in "dural" con-
tainers which can hold 4 Petri dishes (Cooke
et al., 1976). These vessels were made hypoxic
by purging with N2+5% CO2 (BOC Ltd) for
1 h, after which the vessels were sealed and
irradiated at room temperature at a dose rate
of4-2 gray/min. After irradiation, the medium
was removed and replaced with fresh MEM+
15% FCS and the cells incubated for 7-9 days
before scoring for colony formation.
Compounds.-Misonidazole was supplied by
Dr C. Smithen of Roche Products Ltd,
Welwyn Garden City, Herts, and cis-Pt(II)
by Dr K. Harrap, Institute of Cancer Re-
search, Sutton, England.
RESULTS
Cytotoxicity 8tudies
The effect of 5mM MISO (1 mg/ml) on
Chinese hamster V79-379A cells held
under aerobic or hypoxic conditions is
shown in Fig. 1. At this concentration
MISO has no cytotoxic effect on cells in
air over the duration of the experiments
(5 h). In contrast, MISO under hypoxic
conditions reduces the surviving fraction
to 5 x 10-3. In the absence of MISO,
hypoxic cells show no loss of viability.
A similar series of experiments were
done with 10MM cis-Pt(II) (3 pg/ml) under
aerobic and hypoxic conditions at 37(C.
These results are shown in Fig. 2. When
cells are held in air 10tM Ci8-Pt(II) re-
duces survival in an exponential manner
and after 5 h the surviving fraction of cells
is 10-2. However, under hypoxic con-
ditions cells are very much more sensitive
to treatment with cis-Pt(II), and after 5 h
exposure survival is reduced to 10-5.
The results of cytotoxicity experiments
when 5mM MISO and 10MLM cis-Pt(II) are
used in combination are illustrated in
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FIG. 1.- Toxicity of 5mM MISO to V79-379A
cells in vitro. , 5mMl MISO under liypoxic
conditions; 0, 5mm MISO in air; X, cells
un(ler hypoxia alone. Data points are means
from 7 replicate experiments.
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FIG. 2. Toxicity of 10tom cis-Pt(II) to
V79-379A cells int vitro. 0, cells undler
lhypoxic conditions (4 replicate experi-
ments); 0, cells in air (2 replicate experi-
ments).
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F.G. 3.-Toxicity of the drug combination
1OmM cis-Pt(I) + 5mm MISO to V79-379A
cells in vitro. 0.cells under hypoxic condi-
tions (4 replicate experiments); 0, cells
in air (2 replicate experiments). The dashed
lines are the responses for cells treated
with OjtkM Ci8-Pt(II) (Fig. 2). The dotted
line is the response for hypoxic cells treated
with 5mm MISO (Fig. 1).
Fig. 3. In air, the drug combination shows
no greater toxicity thancis-Pt(IS) alone,
but under hypoxic conditions the mixture
of MISO and cis-Pt(II) is considerably
more toxic than either drug alone. Simple
addition of the cytotoxic effects of each
drug indicates that the effect of the drug
combination is, at the very least, additive.
Sensitization experiments
Following the protocol of previous
studies (Adams et al., 1976, 1979) we
determined enhancement ratios for radio-
sensitization of hypoxic Chinese hamster
cells in vitro by MISO and cis-Pt(Ji). At
the concentrations tested, both drugs were
non-toxic to non-irradiated cells over a 2h
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Fim. 4. Survival curves for V79-379A cells
irradiated under hypoxic conditions. +,
hypoxia alone; 0, 5,UM ci8-Pt(II); A,
1mM MISO; 0, 5/M cis-Pt(II) +0-2mM
MISO.
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FiG. 5.-Dependence of enhancement ratio
for irradiated hypoxic V79-379A cells on
MISO concentration. Dashed line, MISO
alone (Adams et al., 1976); 0, MISO + 5,UM
cis-Pt(II); the dotted line is the enhance-
ment ratio for 5,UM Ci8-Pt(II) alone.
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contact time in hypoxia at room tempera-
ture. Full survival curves, examples of
which are shown in Fig. 4, were obtained
for each compound at one or two concen-
trations in N2. Assuming an unchanged
extrapolation number, enhancement ratios
for other concentrations were calculated
from a single survival point (usually
between 2 x 10-2 and 10-1) which was
obtained by appropriate choice of radia-
tion dose.
Enhancement ratios (ER) obtained for
hypoxic cells irradiated in the presence of
MISO alone were similar to those reported
previously for this cell line (Adams et al.,
1976) and this dependence of ER on
MISO concentration is shown by the
dashed line in Fig. 5. The maximum con-
centration of cis-Pt(II) tested was 5 pM,
and this gave routinely an ER of 1 12
(see Fig. 4). For combination studies, the
radiation response of hypoxic cells was
determined for 5/LM cis-Pt(II) with con-
centrations of MISO varying from 10 ztM
up to 2 mm. Fig. 4 shows a survival curve
for hypoxic cells irradiated in the presence
of 0 2mM MISO plus 5/tM cis-Pt(II). This
combination results in a survival curve
which is identical to that obtained for
1mM MISO alone. Values of ER for 5pM
cis-Pt(II) with a range of MISO concen-
trations are shown as the open circles in
Fig. 5. Clearly, the ERs for 5jtM cis-Pt(II)
plus MISO are greater than those for
MISO alone. In addition, the response
curves (Fig. 5) appear parallel, which
suggests that the two compounds show a
degree of additivity that cannot be ex-
plained if they sensitize wholly by the
same mechanism(s).
DISCUSSION
cis-Platinum complexes can increase
the radiation sensitivity of cells in vitro
under both aerobic and hypoxic condi-
tions (Richmond & Powers, 1976; Szumiel
& Nias, 1976; Nias & Szumiel, 1977;
Richmond et al., 1977; Douple & Rich-
mond, 1978) with the greatest effect
apparently onthe hypoxic cells (Richmond
& Powers, 1976; Richmond et al., 1977;
Douple & Richmond, 1978; Nias et al.,
1979). In the present work 5tM cis-Pt(II)
increases the radiation sensitivity of
hypoxic mammalian cells, giving an ER
of 1-12. The combination ofcis-Pt(II) and
MISO gives at least an additive response
for radiation sensitization ofhypoxic cells.
This can be rationalized ifwe consider that
the ER of 5/LM cis-Pt(II) (1.12) is equiva-
lent to 20Mm MISO. On the basis ofsimple
equivalence, if the two compounds are
acting similarly, the combination of 5tM
cis-Pt(II) and 20Mm MISO should give an
ER similar to that seen for 40pM MISO,
viz. 1X20. In fact the observed ER is about
1-40, a value that could only be expected
if the compounds are operating on differ-
ent lesions and/or by different mech-
anism(s). If this effect were to hold for
other cis-Platinum complexes, and if such
complexes in combination with MISO
produced no increased toxicity in man,
this type of drug combination could sub-
stantially increase ERs obtainable in
radiotherapy.
We have demonstrated that, as a cyto-
toxic agent, cis-Pt(II) is considerably
more toxic to hypoxic cells than to
aerobic cells. The difference in toxicity is
seen after only 2h exposure to the drug,
which is likely to preclude the effect being
due to any cell-cycle redistribution in-
duced by hypoxia (Roberts & Fraval,
1978). It is possible that the anaerobic
environment allows biochemical reduction
of cis-Pt(II) to a platinum (I) inter-
mediate. This is a highly reactive species
(Richmond & Simic, 1978) which could
interact with vital cellular macromole-
cules. Alternatively, hypoxia may inhibit
repair of DNA damage caused by cis-
Pt(II), and this may also modify radiation
sensitivity.
The differential cytotoxicity of cis-
Pt(II) may be important in influencing the
efficacy of the cis-platinum complexes
used clinically, since there is evidence that
hypoxic cells may be resistant to some
chemotherapeutic drugs. There are two
possible reasons for this hypoxic resist-
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ance. Firstly, hypoxic cells tend to be
located near necrotic or poorly vascu-
larized regions in tumours, and therefore
these cells are probably less accessible to
some chemotherapeutic agents. Secondly,
clonogenic cells temporarily rendered
hypoxic may become non-cycling, or have
their progression through the cell cycle
slowed down.
Previous work has shown that bleo-
mycin, actinomycin D and adriamycin
are less effective in killing hypoxic than
aerobic cells (Roizin-Towle & Hall, 1978;
Adams et al., 1979; Sutherland et al., 1979;
Smith et al., unpublished data). It has
been suggested that drugs that are speci-
fically toxic to hypoxic cells may be useful
in improving combination chemotherapy.
Some nitro-aromatic and nitro-hetero-
cyclic compounds show this property
(Adams et al., 1980) and one of them,
MISO, has suitable pharmacological
characteristics of bioavailability and
tumour penetration (Dische et al., 1977;
Ash et al., 1979).
The combination ofMISO and cis-Pt(II)
kills hypoxic cells much more effectively
than either drug alone. Therefore, if
potentially clongenic hypoxic cells are
important in tumour response to chemo-
therapy, a combination of MISO and cis-
Pt(II) may be useful, particularly since
the in vitro data reported here show no
additional killing of aerobic cells.
This work was supported in part by NCI Contract
Number NO1-CM-77139.
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